Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
Up-to-now, these pathways are considerably less explored than the main SELENOP/LRP8 pathway, probably, owing to their supplementary function, which may take over only under specific conditions such as SELENOP or LRP8 deficiency
Its important to understand both the bright side and the risks of this therapy to set realistic expectations
Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells
US$ 25.07
US$ 24.36
US$ 20.14
US$ 29.41
US$ 28.70
US$ 24.36
US$ 27.79
